[Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)]

Haematologica. 1990 Jul-Aug:75 Suppl 4:78-81.

[Article in Italian]

Authors

P Mazza¹, M Bocchia, P L Zinzani, F Gherlinzoni, P L Ghetti

Affiliation

¹ Istituto di Ematologia, L. e A. Seràgnoli, Università, Bologna.

PMID: 1981571

No abstract available

Publication types

Review

MeSH terms

Deltaretrovirus / drug effects
Deltaretrovirus Infections / complications
Deltaretrovirus Infections / therapy
Drug Evaluation
Humans
Immunity, Cellular / drug effects
Interferon alpha-2
Interferon-alpha / pharmacology
Interferon-alpha / therapeutic use*
Mycosis Fungoides / etiology
Mycosis Fungoides / microbiology
Mycosis Fungoides / pathology
Mycosis Fungoides / therapy*
Neoplastic Stem Cells / drug effects
Recombinant Proteins
T-Lymphocytes, Helper-Inducer / drug effects
T-Lymphocytes, Helper-Inducer / pathology

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins